30/05/2017 With reference to the agreement signed on 19/04/2017 with the Greek company DEMO SA, C.F.I. SRL has launched Deferoxamine Noridem 2 g in the Italian market. Deferoxamine mesylate is indicated for the treatment of acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias.
C.F.I. SRL on May 2017 presents and inaugurates the new website in a more modern and contemporary version, with a layout compatible with most browsers and smartphones.
19/04/2017 C.F.I. Srl has signed an agreement with the Greek company Demo SA for the exclusive sales and marketing of Deferoxamine Noridem (generic injectable) in Italy. Deferoxamine mesylate is indicated for the treatment of acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias.
28/02/2017 C.F.I. Srl has signed an agreement with the Italian company Industria Farmaceutica Galenica Senese Srl for the exclusive distribution of its entire range of infusion solutions for veterinary use in Italy. The products portfolio includes different solutions in glass bottles, polypropylene bottles and bags and are largely used in veterinary for many applications.
